Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-110632
Filing Date
2024-10-22
Accepted
2024-10-22 18:49:57
Documents
1
Group Members
MICHAEL P. RUBINNORTHPOND VENTURES GP, LLCNORTHPOND VENTURES II GP, LLCNORTHPOND VENTURES III GP, LLCNORTHPOND VENTURES III, LPNORTHPOND VENTURES, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2426605d1_sc13g.htm SC 13G 120286
  Complete submission text file 0001104659-24-110632.txt   122184
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Subject) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94655 | Film No.: 241387488
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7500 OLD GEORGETOWN ROAD SUITE 800 BETHESDA MD 20814
Business Address 7500 OLD GEORGETOWN ROAD SUITE 800 BETHESDA MD 20814 240-800-1200
Northpond Ventures II, LP (Filed by) CIK: 0001869128 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G